Krausz M - Search Results

1

Comorbidity of schizophrenia and galactosemia: effective clozapine treatment with weight gain.

Haasen C, Lambert M, Yagdiran O, Karow A, Krausz M, Naber D. Haasen C, et al. Among authors: krausz m. Int Clin Psychopharmacol. 2003 Mar;18(2):113-5. doi: 10.1097/00004850-200303000-00009. Int Clin Psychopharmacol. 2003. PMID: 12598824

2

Objective and subjective efficacy as well as tolerability of olanzapine in the acute treatment of 120 patients with schizophrenia spectrum disorders.

Lambert M, Holzbach R, Moritz S, Postel N, Krausz M, Naber D. Lambert M, et al. Among authors: krausz m. Int Clin Psychopharmacol. 2003 Sep;18(5):251-60. doi: 10.1097/00004850-200309000-00001. Int Clin Psychopharmacol. 2003. PMID: 12920385 Clinical Trial.

3

Dosage of conventional neuroleptic medication and subjective cognitive functioning in schizophrenia.

Krausz M, Moritz S, Lambert M, Naber D. Krausz M, et al. Int Clin Psychopharmacol. 2000 Mar;15(2):77-81. doi: 10.1097/00004850-200015020-00003. Int Clin Psychopharmacol. 2000. PMID: 10759338

4

Switching to amisulpride due to hepatic complications.

Yagdiran O, Haasen C, Nika E, Krausz M, Naber D. Yagdiran O, et al. Among authors: krausz m. Eur Psychiatry. 2002 May;17(3):170-1. doi: 10.1016/s0924-9338(02)00641-7. Eur Psychiatry. 2002. PMID: 12052579 No abstract available.

5

Neuroleptic-induced extrapyramidal symptoms are accompanied by cognitive dysfunction in schizophrenia.

Krausz M, Moritz SH, Naber D, Lambert M, Andresen B. Krausz M, et al. Eur Psychiatry. 1999 Apr;14(2):84-8. doi: 10.1016/s0924-9338(99)80722-6. Eur Psychiatry. 1999. PMID: 10572331

6

Relationship between neuroleptic dosage and subjective cognitive dysfunction in schizophrenic patients treated with either conventional or atypical neuroleptic medication.

Moritz S, Woodward TS, Krausz M, Naber D; PERSIST Study Group. Moritz S, et al. Among authors: krausz m. Int Clin Psychopharmacol. 2002 Jan;17(1):41-4. doi: 10.1097/00004850-200201000-00007. Int Clin Psychopharmacol. 2002. PMID: 11800506 Clinical Trial.

7

PANSS syndromes and quality of life in schizophrenia.

Karow A, Moritz S, Lambert M, Schoder S, Krausz M. Karow A, et al. Among authors: krausz m. Psychopathology. 2005 Nov-Dec;38(6):320-6. doi: 10.1159/000088921. Epub 2005 Oct 12. Psychopathology. 2005. PMID: 16224206

8

Correlates of subjective well-being in schizophrenic patients treated with atypical antipsychotics.

Schimmelmann BG, Moritz S, Karow A, Schafer I, Bussopulos A, Golks D, Krausz M, Naber D, Lambert M. Schimmelmann BG, et al. Among authors: krausz m. Int J Psychiatry Clin Pract. 2005;9(2):94-8. doi: 10.1080/13651500510018266. Int J Psychiatry Clin Pract. 2005. PMID: 24930789

9

Belief systems as coping factors for traumatized refugees: a pilot study.

Brune M, Haasen C, Krausz M, Yagdiran O, Bustos E, Eisenman D. Brune M, et al. Among authors: krausz m. Eur Psychiatry. 2002 Dec;17(8):451-8. doi: 10.1016/s0924-9338(02)00708-3. Eur Psychiatry. 2002. PMID: 12504261

10

Smoking cocarettes: a less harmful alternative of cocaine use?

Haasen C, Prinzleve M, Reimer J, Krausz M. Haasen C, et al. Among authors: krausz m. Eur Addict Res. 2003 Oct;9(4):188-9. doi: 10.1159/000072225. Eur Addict Res. 2003. PMID: 12970588

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

384 results

Search Page

Filters